Bright Minds Biosciences (DRUG) Free Cash Flow: 2019-2024
Historic Free Cash Flow for Bright Minds Biosciences (DRUG) over the last 6 years, with Sep 2024 value amounting to -$1.4 million.
- Bright Minds Biosciences' Free Cash Flow fell 3441.42% to -$9.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$5.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.4 million for FY2024, which is 73.89% up from last year.
- Per Bright Minds Biosciences' latest filing, its Free Cash Flow stood at -$1.4 million for FY2024, which was up 73.89% from -$5.2 million recorded in FY2023.
- Bright Minds Biosciences' Free Cash Flow's 5-year high stood at -$214,556 during FY2020, with a 5-year trough of -$10.6 million in FY2022.
- Moreover, its 3-year median value for Free Cash Flow was -$5.2 million (2023), whereas its average is -$5.7 million.
- As far as peak fluctuations go, Bright Minds Biosciences' Free Cash Flow crashed by 2,599.19% in 2021, and later soared by 73.89% in 2024.
- Yearly analysis of 5 years shows Bright Minds Biosciences' Free Cash Flow stood at -$214,556 in 2020, then plummeted by 2,599.19% to -$5.8 million in 2021, then plummeted by 83.78% to -$10.6 million in 2022, then soared by 51.05% to -$5.2 million in 2023, then soared by 73.89% to -$1.4 million in 2024.